Irritable Bowel Syndrome With Constipation
27
2
2
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
14 trials with published results (52%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
7.4%
2 terminated out of 27 trials
90.5%
+3.9% vs benchmark
26%
7 trials in Phase 3/4
74%
14 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 19 completed trials
Clinical Trials (27)
A Study of Virtual Reality and Linaclotide for IBS-C
Effect of Tai Chi as Treatment for IBS-C
Electro-acupuncture for Irritable Bowel Syndrome With Constipation
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)
Home Transcutaneous Electrical Acustimulation (TEA)
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
IBS-C Questionnaire Study
A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations
Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome
Efficacy and Safety of SYN-010 in IBS-C
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
An Evaluation of Cultured Milk Drink on Immune Status of Patients With Irritable Bowel Syndrome: Constipation Predominant
Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation